Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only ... Source: FactSet Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to ...

HQH's high yield is unsustainable, relying on capital gains and potentially forcing premature sales. Read why I'm bearish on ...

announced today its common stock will be added to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective prior to market open on Monday, December 23, 2024. LONDON & NEW YORK, November 25 ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only ... Source: FactSet Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to ...

It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the NYSE Biotechnology Index, by using representative sampling ...

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison. Important Information Please note the value of investments ...

Goldman Sachs has spotlighted an often-overlooked sector poised to benefit from lower borrowing costs: biotechnology stocks.